MOL BIOL REP 润色咨询

MOLECULAR BIOLOGY REPORTS

出版年份:1973 年文章数:5502 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:0.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-04-08 曼~

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤;分子机制;miRNA
    经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!

    15

    展开15条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-09-17 ms2000000622008027

    投稿到接收35天

    11

    展开11条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-03-03 sissijustin

    被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2020-05-05 147aafc3m28暂无昵称

    建议转投的,一直是transferred submission received一周了,正常吗?

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2022-03-25 ms3000000054172211

    审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-10-30 zyecce

    偏重的研究方向:分子机制;基础
    经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-05-21 99不bia叽嘴

    偏重的研究方向: 动物分子遗传
    经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-08-19 hfcj0370

    投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2019-05-06 ms9430612511402566

    另一个杂志推荐投的这个,一直在submit 20天了,小急

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=955139, encodeId=fb12955139fe, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;分子机制;miRNA<br>经验分享:第一次投稿,建议转投的,一篇简单的综述,1月20日提交,3月8日给了审稿意见,建议小修,意见都很中肯,对每一条意见都认真回答了以后,4月2日提交修改稿,4月7日接收。整体速度很快,新手写文章投稿,虽然分数不高但已经很满足了,给自己莫大的鼓励。也祝大家都成功!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23455241794, createdName=曼~, createdTime=Thu Apr 08 09:52:07 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052307, encodeId=07f9105230e66, content=投稿到接收35天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Fri Sep 17 12:56:20 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945315, encodeId=f97e94531595, content=被"Molecular and Cellular Biochemistry 建议转投这里,但是我什么都没做,文章状态就显示转投了,而且不知道去哪里查文章状态<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f94d1984915, createdName=sissijustin, createdTime=Wed Mar 03 23:55:49 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590261, encodeId=9a8f59026142, content=建议转投的,一直是transferred submission received一周了,正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3af5234918, createdName=147aafc3m28暂无昵称, createdTime=Tue May 05 00:00:00 CST 2020, time=2020-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205812, encodeId=2c931205812c0, content=审稿速度很快,很快就接收了,但proof很慢,2周了还没给正式的proof,你们的proof都多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3dad5515566, createdName=ms3000000054172211, createdTime=Fri Mar 25 11:05:55 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065390, encodeId=090110653905c, content=偏重的研究方向:分子机制;基础<br>经验分享:投稿历时两个月接收,审稿速度很快,10月29返修,30号就接收了,很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fd35573058, createdName=zyecce, createdTime=Sat Oct 30 23:57:35 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967431, encodeId=48cb96e4315e, content=偏重的研究方向: 动物分子遗传 <br>经验分享:各位友友,5-18显示 review completed,5-20又under review了是几个意思哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60b12061945, createdName=99不bia叽嘴, createdTime=Fri May 21 11:38:45 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009353, encodeId=9044100935391, content=投稿Molecular and Cellular Biochemistry,被建议转到这个杂志,试一试吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fafc4838963, createdName=hfcj0370, createdTime=Thu Aug 19 09:03:51 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851213, encodeId=ade385121335, content=另一个杂志推荐投的这个,一直在submit 20天了,小急 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 06 11:53:07 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586144, encodeId=b5f758614413, content=请问可以不选OA吗?如果不选OA还需要版面费吗?<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>过万</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e135310803, createdName=14888784m63(暂无昵称), createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2020-03-08 14888784m63(暂无昵称)

    请问可以不选OA吗?如果不选OA还需要版面费吗?132****5832暂无昵称 2019-10-25 00:00:00 发表:
    过万

    132****5832暂无昵称 2019-10-25 00:00:00 发表: 过万

    6

    展开6条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分